Compare MetLife Inc. Common Stock (MET) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MetLife Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? MetLife Inc. Common Stock trades at $98.28 (market cap $62.58B), while Roivant Sciences Ltd. Common Shares trades at $35.54 (market cap $24.72B). The key difference: MetLife Inc. Common Stock is far larger — about 2.5× Roivant Sciences Ltd. Common Shares's market cap, and MetLife Inc. Common Stock pays a 2.41% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold MetLife Inc. Common Stock for 1 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| MET | ROIV | |
|---|---|---|
Market Cap | $62.58B | $24.72B |
Volume | 3,009,466 | 6,279,442 |
Sector | Financials | Health |
52-Week High | $99.95 | $41.81 |
52-Week Low | $67.70 | $16.04 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $83.50B | $20.99B |
Dividend Yield | 2.41% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
